SEP 13, 2017 01:30 PM PDT
Integration of the Simplexa C. difficile Direct assay in a two-step algorithm for the laboratory diagnosis of C. difficile
Presented at the Microbiology & Immunology 2017 Virtual Event
SPONSORED BY: DiaSorin
CONTINUING EDUCATION (CME/CE/CEU) CREDITS: P.A.C.E. CE | Florida CE
1 1 35

Speakers:
  • Professor of Pathology and Laboratory Medicine, University of Louisville
    Biography
      Dr. Snyder is the Medical Director of the Clinical Microbiology & Molecular Diagnostics Laboratory at the University of Louisville Hospital, and Professor of Pathology and Laboratory Medicine in the Department of Pathology and Laboratory Medicine at the University of Louisville, School of Medicine.

      He has been a part of ASM for many years. He currently serves on the Editorial Board for the Journal of Clinical Microbiology, is a member of the APHL Biosafety/Biosecurity Committee, and a past member of the APHL Sentinel Laboratory Partners Outreach Committee. He is also currently a member of the South Central Association for Clinical Microbiology Audioconference Planning Committee and President Elect of SCACM.

      He has authored or co-authored over 60 publications and was the recipient of the TREK Diagnostic ABMM/ABMLI Professional Recognition Award at ASM in 2009.

    Abstract:

    Clostridium difficile is a major pathogen responsible for infectious diarrhea in healthcare settings. This presentation will review the data from a study comparing the new Simplexa® C. difficile Direct assay with our in-house two-step algorithm and two additional PCR-based assays (Great Basin, GeneXpert Infinity) in which PCR was utilized as a confirmatory rather than a direct assay.


    Show Resources
    Loading Comments...